ReviewCureus2026

Bruton Tyrosine Kinase Inhibitor-Based Therapy Versus Rituximab-Containing Regimens for Chronic Lymphocytic Leukemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Sadia Yousaf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.